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ABSTRACT The influence of the skin microbiota on host susceptibility to infectious agents is largely unexplored. The skin har-
bors diverse bacterial species that may promote or antagonize the growth of an invading pathogen.We developed a human infec-
tion model forHaemophilus ducreyi in which human volunteers are inoculated on the upper arm. After inoculation, papules
form and either spontaneously resolve or progress to pustules. To examine the role of the skin microbiota in the outcome of
H. ducreyi infection, we analyzed the microbiomes of four dose-matched pairs of “resolvers” and “pustule formers” whose inoc-
ulation sites were swabbed at multiple time points. Bacteria present on the skin were identified by amplification and pyrose-
quencing of 16S rRNA genes. Nonmetric multidimensional scaling (NMDS) using Bray-Curtis dissimilarity between the prein-
fection microbiomes of infected sites showed that sites from the same volunteer clustered together and that pustule formers
segregated from resolvers (P 0.001, permutational multivariate analysis of variance [PERMANOVA]), suggesting that the pre-
infectionmicrobiomes were associated with outcome. NMDS using Bray-Curtis dissimilarity of the endpoint samples showed
that the pustule sites clustered together and were significantly different than the resolved sites (P 0.001, PERMANOVA), sug-
gesting that the microbiomes at the endpoint differed between the two groups. In addition toH. ducreyi, pustule-forming sites
had a greater abundance of Proteobacteria, Bacteroidetes,Micrococcus, Corynebacterium, Paracoccus, and Staphylococcus spe-
cies, whereas resolved sites had higher levels of Actinobacteria and Propionibacterium species. These results suggest that at base-
line, resolvers and pustule formers have distinct skin bacterial communities which change in response to infection and the resul-
tant immune response.
IMPORTANCE Human skin is home to a diverse community of microorganisms, collectively known as the skin microbiome.
Some resident bacteria are thought to protect the skin from infection by outcompeting pathogens for resources or by priming
the immune system’s response to invaders. However, the influence of the skin microbiome on the susceptibility to or protection
from infection has not been prospectively evaluated in humans. We characterized the skin microbiome before, during, and after
experimental inoculation of the arm withHaemophilus ducreyi in matched volunteers who subsequently resolved the infection
or formed abscesses. Our results suggest that the preinfectionmicrobiomes of pustule formers and resolvers have distinct com-
munity structures which change in response to the progression ofH. ducreyi infection to abscess formation.
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The skin microbiome is dominated by members of four phyla,Actinobacteria, Firmicutes, Proteobacteria, and Bacteroidetes.
Within these groups, consistently present and abundant genera in-
cludePropionibacterium,Corynebacterium, Staphylococcus,Micrococ-
cus, Streptococcus, and Brevibacterium (1–4). Human skin is charac-
terized by three physiologically distinct microenvironments:
sebaceous, moist, and dry. Similar skin niches tend to support com-
parable bacterial communities. Compared to sebaceous and moist
sites, dry skin appears to be inhabited by a more mixed population
(1). The volar forearm supports a highly rich bacterial community
(high number of bacterial operational taxonomic units [OTUs]) and
one of the most highly diverse communities (relatively even distribu-
tion of bacterial OTUs) (1, 5). The inherent richness and diversity
observed in dry skin make it difficult to define a “core” skin micro-
biome for a given anatomic site. For example, one study detected a
greater abundance of Betaproteobacteria and Flavobacteriales (1),
whereas another study found similar numbers of Betaproteobacteria,
Firmicutes, and Actinobacteria on the volar forearms of healthy vol-
unteers (2). Furthermore, although resampling of the same site over
time showed higher intrapersonal than interpersonal community
consensus, minimal longitudinal stability was observed in the volar
forearm microbiome (1, 2).
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Despite the challenge of defining a “normal” skin microbiome,
comparing the microbiomes of diseased and normal skin could
further our understanding of the many factors that contribute to,
or result from, infection and autoimmune disease. The skin har-
bors diverse bacterial species that may promote or antagonize the
growth of an invading pathogen (6). Recent studies have corre-
lated the presence of certain bacteria with specific disease states.
Compared to healthy skin, Firmicutes are relatively more abun-
dant andActinobacteria andProteobacteria are relatively less abun-
dant in psoriatic lesions (3). In patients with the inflammatory
skin disorder atopic dermatitis, increasing disease severity corre-
lates with decreased microbial diversity overall and an increased
prevalence of staphylococci, including both S. epidermidis and
S. aureus (7). These studies indicate that several skin disorders are
characterized by shifts in the skin microbiome, most notably, loss
of protective bacteria and outgrowth of pathogenic bacteria.
However, whether the skin microbiome influences or is influ-
enced by infection with a skin pathogen is unknown.
H. ducreyi is a fastidious, Gram-negative facultative anaerobe
that causes sexually transmitted genital ulcers (GU) called chan-
croid. Chancroid is endemic in resource-poor areas in Africa,
Asia, and Latin America and is a public health problem because it
facilitates the transmission of human immunodeficiency virus
type 1 (HIV-1) (8). Due to syndromic management of GU, the
prevalence of chancroid is now undefined but appears to have
declined in several regions of endemicity (9).
Chronic cutaneous ulcers (CU) in the South Pacific islands and
equatorial Africa are usually attributed to yaws, an infection
caused byTreponema pallidum subsp. pertenue, which is spread by
nonsexual personal contact. However, H. ducreyi has recently
emerged as a major etiological agent of CU (10–12). In an area of
Papua New Guinea where yaws is endemic, the community prev-
alence of CU that contained H. ducreyi DNA was 3%; H. ducreyi
DNA was detected in nearly 60% of CU lesions, while T. pallidum
subsp. pertenue DNA was detected in only 31% of lesions (10). In
the Solomon Islands and in Ghana, H. ducreyi sequences are pres-
ent in 32% and 9% of CU lesions, respectively; in both of these
studies, H. ducreyi was the only pathogen detected (11, 12). Al-
though H. ducreyi is highly susceptible to azithromycin (13), mass
treatment with azithromycin in Papua New Guinea reduced the
overall prevalence of CU by 90% but failed to reduce the propor-
tion of ulcers that contained H. ducreyi DNA (14). The high prev-
alence of CU caused by H. ducreyi and the failure of mass treat-
ment to eradicate H. ducreyi infection underscores the need to
understand the factors that contribute toH. ducreyipathogenicity.
To understand H. ducreyi pathogenesis, we developed an ex-
perimental infection model in which healthy adult volunteers are
inoculated on the upper arm over the deltoid area with 1 to
100 CFU of the GU strain 35000HP via puncture wounds. Whole-
genome sequencing shows that recently discovered CU strains are
derived from the same lineage and are nearly genetically identical
to 35000HP (15); thus, the model is relevant to both GU and CU.
In the model, H. ducreyi initially causes papule formation at ap-
proximately 90% of the inoculated sites. All papules spontane-
ously resolve in approximately 30% of volunteers (resolvers),
whereas 70% of the volunteers form one or more pustules (pustule
formers) (16). Men are 2-fold more likely than women to form
pustules, indicating that gender influences outcome (16). Gender-
matched resolvers and pustule formers who are infected a second
time tend to have the same outcome as their initial infection, sug-
gesting that host factors in addition to gender influence outcome
(17).
Within 24 h of experimental infection with H. ducreyi, macro-
phages and polymorphonuclear leukocytes (PMN) traffic on col-
lagen and fibrin scaffolds deposited in the wounds, forming mi-
cropustules in the dermis and epidermis (18, 19). In pustule
formers, PMN accumulate and form an abscess that eventually
erodes the epidermis (18, 19). Below the abscess is a macrophage
collar admixed with regulatory T cells (Treg) and a dermal infil-
trate of memory and effector memory subsets of CD4 and CD8 T
cells, activated natural killer (NK) cells, myeloid dendritic cells
(DC), and Langerhans cells (19–25). DC likely phagocytoseH. du-
creyi, migrate to regional nodes, and sensitize naive T cells to be-
comeH. ducreyi-specific memory cells that eventually home to the
lesions (23, 26). Throughout experimental infection and in natu-
ral ulcers, H. ducreyi associates with PMN and macrophages,
which fail to ingest the organism (19, 25, 27). Thus, evasion of
phagocytosis is a major mechanism of H. ducreyi survival. In re-
solvers, the mechanism of resolution is unknown but is presum-
ably due to enhanced phagocytic clearance of the organism at the
papular stage of disease and the subsequent termination of the
inflammatory response.
Comparison of gene expression profiles of biopsy specimens
obtained from resolvers and pustule formers who were reinfected
indicated that the two groups share a core immune response but
that pustule formers also express transcripts consistent with a hy-
perinflammatory, dysregulated state (28). When infected with
H. ducreyi, myeloid DC derived from resolvers express transcripts
consistent with promoting Th1 and Th17 responses, while DC
from pustule formers express transcripts that should promote Th1
and Treg responses (28). A combined Th1 and Th17 response may
result in a cytokine environment that promotes phagocytosis and
disease resolution, whereas a combined Th1 and Treg response
may result in a cytokine environment that inhibits phagocytosis
and promotes abscess formation. Transcripts associated with M2
macrophage polarization are also upregulated in resolvers (28,
29). M2 cells are more phagocytic for and equally potent at killing
H. ducreyi than M1 cells (29). Thus, M1 polarization may lead to
hyperinflammation and bacterial persistence in pustule formers,
whereas a switch from M1 to M2 may result in resolution of in-
flammation and bacterial clearance (29). Taken together, these
data suggest that differential innate immune responses play a ma-
jor role in the outcome of H. ducreyi infection (28, 29).
The presence of serum in the wounds and the recruitment of
PMN, macrophages, dendritic cells, NK cells, and T cells lead to a
local environment marked by activated complement, proinflam-
matory cytokines, antimicrobial peptides, and an increased con-
centration of reactive oxygen and nitrogen species. Although
H. ducreyi has mechanisms that allow it to survive in an abscess
and resist phagocytic uptake, complement-mediated killing, anti-
microbial peptides, and reactive oxygen species (30–33), these
nonspecific host defenses likely affect the resident microbiota. In-
flammatory responses are known to change the composition of
the microbiome (34), but whether the cutaneous immune re-
sponse to an infectious agent influences the skin microbiome is
unknown.
As the microbiome influences the outcome of certain infec-
tious disease (35), we hypothesized that in addition to the quality
of the innate immune response and gender, the structure of the
skin microbiome may also play a role in the ability of H. ducreyi to
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progress to abscess formation in some hosts and resolve in others.
Here we evaluated the skin microbiome before and after inocula-
tion of human volunteers to investigate baseline differences in
pustule formers and resolvers and changes that occur throughout
experimental H. ducreyi infection. In accordance with the damage
response framework of infectious diseases (36), “infection” is de-
fined to include both the contributions of H. ducreyi and the dif-
ferential inflammatory responses observed in pustule formers and
resolvers. In an attempt to incorporate the microbiota into the
damage response framework (35), we asked whether the micro-
biome present prior to infection was associated with host suscep-
tibility to H. ducreyi infection and what, if any, changes in the
microbiome occurred following infection with H. ducreyi. This is
the first prospective study to assess associations among the skin
microbiome, a bacterial pathogen, and differential immune re-
sponses in humans.
RESULTS
Infection outcomes in volunteers. Four sets of dose-matched re-
solvers and pustule formers, who were inoculated with estimated
delivered doses of 32 to 69 CFU of strain 35000HP, were included
in the study (Table 1). In the model, infection with these doses
typically results in the formation of a papule within 24 h (16). By
day 1, papules developed at 22 of 24 inoculated sites (Table 1).
Volunteers 396, 391A, 407, and 408 resolved all papules between
days 2 and 13. Volunteers 395, 406, and 409 formed pustules at 2
of the 3 inoculated sites, while volunteer 398 formed pustules at all
3 sites (Table 1).
Sample processing and enrichment of skin-specific se-
quences. We processed skin swabs collected prior to inoculation,
at days 1, 2, and 5 postinoculation, at the clinical endpoint, and at
the test-of-cure visit (TOC) (Fig. 1). Thus, each volunteer pro-
vided 18 clinical samples. Of the 144 swabs, 6 yielded insufficient
DNA for 16S rRNA gene PCR (see Table S1 in the supplemental
material). High-quality sequences were obtained from the re-
maining 138 samples.
Because skin swabs yield relatively low bacterial numbers, en-
vironmental contamination can affect the analysis. To control for
contamination, a swab that was dipped in the phosphate-buffered
saline (PBS) used to moisten the skin swabs at each visit was pro-
TABLE 1 Responses to inoculation with live H. ducreyi 35000HPa
Volunteer no.,
gender
No. of days
infected
Site
no.
Inoculum
(CFU)
Clinical
endpoint
Induration size and presence of pustule(s) on
postinoculation dayb:
1 2 5 Endpoint
395, F 7 1 32 R 6 6 () 9 9 () R R
2 P 6 6 () 8 9 () 4 4 () 4 4 ()
3 P 5 5 () 5 8 () 4 4 () 4 4 ()
396, F 13 1 32 R 3 3 () 4 4 () 6 7 () R
2 R ND ND ND ND
3 R ND ND ND ND
398, M 6 1 63 P 5 5 () 5 6 () 9 7 () 10 15 ()
2 P 4 4 () 5 5 () 5 5 () 6 6 ()
3 P 5 5 () 5 5 () 6 5 () 5 6 ()
391A, M 7 1 63 R 4 4 () R R R
2 R 2 2 () 2 2 () R R
3 R 3 3 () 4 4 () 3 2 () R
406, M 6 1 69 R 2 2 () 2 2 () R R
2 P 4 4 () 3 3 () 4 4 () 5 5 ()
3 P 4 4 () 3 3 () 15 7 () 7 7 ()
407, M 9 1 69 R 4 4 () 5 5 () Rc R
2 R 4 4 () 5 5 () R R
3 R 4 4 () 5 5 () R R
408, F 8 1 35 R 2 2 () 3 3 () 3 3 () R
2 R 4 4 () R R R
3 R 3 3 () R R R
409, M 7 1 35 P 3 3 () 3 3 () 8 8 () 12 10 ()
2 R 3 3 () 2 2 () R R
3 P 4 4 () 5 4 () 5 5 () 12 12 ()
a Abbreviations: F, female; M, male; ND, no disease; R, resolved; P, pustule.
b Induration dimensions are reported in millimeters; and symbols in parentheses indicate the presence or absence of pustules, respectively.
c Subject 407 did not achieve the endpoint on day 5 because disease was present at sites injected with the mutant strain.
FIG 1 Schematic of times for swab sampling chosen for processing prior to and following experimental inoculation with H. ducreyi.
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cessed in parallel to the skin swabs. Of 48 PBS control samples,
sequences were obtained from 46. After bacterial OTUs were as-
signed, the OTUs that were less than 2-fold greater in the skin
samples over the PBS controls were discarded as likely environ-
mental contaminants. Initially 2,462 OTUs were formed at greater
than 97% identity from 309,161 16S rRNA sequence reads. Apply-
ing the 2-fold cutoff removed 16% of the OTUs, resulting in 2,068
OTUs and 190,569 reads from the samples. The number of cor-
rected reads obtained from each site is shown in Table S1 in the
supplemental material; all subsequent analyses were performed
on this corrected data set. The average corrected number of reads
per sample was 1,347.
We defined the skin microbiome as the collective bacterial
community identified by the V1-V3 region of the 16S rRNA gene.
OTUs were grouped according to genus and phylum to determine
the relative abundances at these taxonomic levels. Species desig-
nations were based on the best alignment of an OTU consensus
sequence to a species in the RDP or NCBI database; two species are
listed in the cases of identical hits.
Characteristics of the upper deltoid microbiome. We exam-
ined the relative abundance and prevalence of major taxa in all
swabs collected at preinfection, prior to cleansing and inoculation
with H. ducreyi. As observed in other studies characterizing dry
skin, the microbiome of the upper deltoid region was dominated
by Actinobacteria (resolvers versus pustule formers, 50% versus
41%), Firmicutes (32% versus 18%), Proteobacteria (7% versus
34%) and, to a lesser extent, Bacteroidetes (6% versus 2%) (Fig. 2).
Of the remaining taxa, approximately 2% belonged to 11 minor
phyla and the remaining 2% were unclassified at the phylum level
(Fig. 2).
The prevalence of the four major phyla differed between each
volunteer and changed over the course of the study (see Fig. S1 in
the supplemental material). In general, the microbiomes were
similar at the 3 sampling sites from each volunteer, at both the
phylum (see Fig. S1) and genus (Fig. 3) levels.
The most abundant genera consisted primarily of taxa within
one of the four dominant phyla. The distribution of the top 20
genera at each site on each day is shown in Fig. 3. Across all days,
the most prevalent members of Actinobacteria were Propionibac-
terium (resolvers versus pustule formers, 33% versus 15%), Co-
rynebacterium (11% versus 10%), and Micrococcus (0.8% versus
8%) (Table 2). The most abundant taxa at the OTU level were
classified as Propionibacterium acnes, Corynebacterium tuberculo-
stearicum, Corynebacterium accolens/Corynebacterium aurimuco-
sum, Corynebacterium afermentans, Corynebacterium mucifaciens,
and Micrococcus luteus. Within the Firmicutes, Staphylococcus
(16% versus 14%), Streptococcus (7% versus 1%), and Finegoldia
(1% versus 0.4%) were the most prevalent genera. The most abun-
dant OTUs in these genera were Staphylococcus caprae/Staphylo-
coccus capitis, Staphylococcus petrasii, and Streptococcus mitis.
Members of the Proteobacteria, including Paracoccus (0.1% versus
18%) and Haematobacter (0.05% versus 7%), were detected pri-
marily in pustule formers; these genera were dominated by Para-
coccus aminovorans, Paracoccus versutus, and Haematobac-
ter massiliensis. The most abundant genera of Bacteroidetes were
Porphyromonas (1.7% versus 0.2%) and Chryseobacterium (0.2%
versus 1.5%).
The microbiome at preinfection differs between resolvers
and pustule formers. To understand if the microbiome present
prior to inoculation influences disease susceptibility, we analyzed
the samples collected at preinfection. We hypothesized that the
microbiomes in resolvers would have different diversity levels
than those of pustule formers; that is, the bacterial communities
may harbor different amounts of unique taxa (richness) that are
present in relatively different proportions (evenness). To assess
this hypothesis, alpha diversity measurements including richness,
evenness, and diversity were determined using the Chao1 and
ACE, Pielou, and Shannon and Simpson algorithms, respectively.
No significant differences were detected at preinfection for any of
these parameters between those volunteers who eventually re-
solved infection versus those who formed pustules (data not
shown).
To assess differences in bacterial community compositions, we
determined the Bray-Curtis dissimilarity, which measures how
similar two communities are based on taxa present and their rel-
ative abundances. Nonmetric multidimensional scaling (NMDS)
using Bray-Curtis dissimilarities showed that the microbiomes of
the sites clustered by host as well as by the clinical outcomes
(Fig. 4). The permutational multivariate analysis of variance
(PERMANOVA) test indicated that the difference between resolv-
ers and pustule formers was statistically significant (P  0.001).
We also performed Unifrac analysis, which measures differences
in communities based on phylogenetic relationships among bac-
terial taxa. Weighted and unweighted Unifrac analysis results cor-
roborated the Bray-Curtis analysis; significant separation was ob-
served between pustule formers and resolvers (data not shown).
Thus, the microbiomes of resolvers and pustule formers are dif-
ferent from each other.
Pustule formers share common microbiomes at the end-
point. We next asked if pustule formation or infection resolution
FIG 2 Distribution of the four dominant phyla in resolvers (A) and pustule formers (B) preinfection. Pie charts represent the percent proportions of each
phylum across all days from the corrected sequence data, with averages and standard deviations shown for Actinobacteria, Firmicutes, Proteobacteria, and
Bacteroidetes.
van Rensburg et al.
4 ® mbio.asm.org September/October 2015 Volume 6 Issue 5 e01315-15
correlated with changes in the microbiomes throughout the infec-
tion. We hypothesized that outgrowth of H. ducreyi in pustule
formers would decrease the diversity, richness, and evenness of
the microbiome. Samples collected at days 1, 2, and 5 and at the
clinical endpoint were analyzed. Chao1 and ACE richness, Shan-
non and Simpson diversity indices, and Pielou evenness did not
differ significantly between resolved and pustule sites (data not
shown). Thus, we were not able to detect differences in the alpha
diversity associated withH. ducreyi infections based on the current
sample size.
The NMDS using Bray-Curtis dissimilarities of endpoint sam-
ples showed that pustule sites clustered together but away from
the resolved sites (Fig. 5), and the separation of pustule formers
and resolvers was statistically significant (P  0.001, PER-
MANOVA). Sites from the same individual tended to cluster to-
gether; even the resolved sites from the pustule formers clustered
with their adjacent pustule-forming sites, suggesting that the host
effect remained a strong factor influencing the microbiome
(Fig. 5). In contrast to the preinfection data, at the endpoint the
resolver sites did not cluster together, while sites from the pustule
formers appeared to cluster. Weighted and unweighted Unifrac
analyses also showed statistically significant separation of pustule
formers and resolvers (data not shown).
Dynamics of themicrobiomeduring experimental infection.
In addition to differences at preinfection and the endpoint be-
tween resolvers and pustule formers, we were interested in how
the microbiomes changed over the course of the experimental
infection. To investigate kinetic changes in alpha diversity, we
measured the changes in Chao1 and ACE richness, Shannon and
Simpson diversity indices, and Pielou evenness on days 1, 2, 5, the
endpoint, and TOC relative to preinfection (baseline). We ex-
pected to observe a difference in the community dynamic, for
example, a relative loss in diversity as pustules developed. How-
ever, no significant differences in the kinetic alpha diversity mea-
surements were observed throughout experimental infection
(data not shown).
We also compared the Bray-Curtis dissimilarities on each day
relative to those at preinfection. We hypothesized that as H. du-
creyi grew in the abscess, a relative change in community compo-
sition would occur. Although the Bray-Curtis dissimilarities at
preinfection and at endpoint were significantly different between
pustule formers and resolvers (Fig. 4 and 5), the relative change in
FIG 3 Distribution of the 20 most abundant genera, other classified genera, and unclassified genera in resolvers (A) and pustule formers (B). All samples for
which sequence data were obtained are shown; no sequences were obtained for the missing samples.
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beta diversity on each day compared to preinfection was not sig-
nificantly different between pustule formers and resolvers (data
not shown).
Detection ofH. ducreyi.H. ducreyi 16S rRNA gene sequences
were detected in 14 samples. Importantly, no H. ducreyi was de-
tected in swabs collected at preinfection or at TOC, and no H. du-
creyiwas detected in the PBS controls. Among the resolvers,H. du-
creyi was detected in 3 samples; one read of H. ducreyi was
observed in each of the day 1 samples from volunteers 396 and 408
and in the endpoint sample from volunteer 408. H. ducreyi was
identified in 11 samples obtained from pustule formers. Samples
from all 3 sites of volunteer 398 contained H. ducreyi, and H. du-
creyi 16S rRNA gene sequences comprised 15 and 33% of the total
reads in two of the endpoint swabs for this volunteer. H. ducreyi
positive surface cultures were obtained from the 3 samples of vol-
unteer 398, who had the highest H. ducreyi reads. Additionally,
H. ducreyi reads ranged from 1 to 12% of the total reads in 3
pustule sites among volunteers 406 (two positive sites) and 409
(one positive site).
Prevalence rates of specific taxa correlate with infection out-
come. To investigate whether specific bacteria were associated
with infection resolution or progression, we compared the relative
abundance of taxa in resolved and pustule-forming sites. Al-
though the Bray-Curtis analysis (Fig. 4 and 5) and phylum- and
genus-level distributions (Fig. 3; see also Fig. S1 in the supplemen-
tal material) showed that the microbiomes of these 3 resolved sites
resembled their respective adjacent pustule-forming sites, we ex-
cluded these 3 sites so that we could compare resolved sites from
resolvers to pustule-forming sites from pustule formers. We only
analyzed taxa that were present in at least 25% of the sites and
comprised 1% (at the phylum or genus level) or 0.1% (at the OTU
level) of the microbiome. We analyzed these taxa using two statis-
tical models, the negative binomial (NB) model and the zero-
inflated negative binomial (ZINB) mixed model. The NB model
accounted for the small sample size, and the ZINB model also
factored in the large proportion of zero values observed for certain
taxa in the microbiome samples (37). P values were corrected for
multiple comparisons. Taxa that were significantly different (P
0.05) between resolvers and pustule formers by either or both the
NB and ZINB models were considered signature bacteria. We
used the Akaike Information Criterion (AIC) value to measure the
quality of the fit of the model for the data set. Analyses of the data
TABLE 2 Relative abundance and prevalence levels of major taxa at preinfectiona
Major taxonomy group
% relative abundance
(mean SD) No. of subjects colonizedb
R P R P
Actinobacteria
Propionibacterium acnes 33.5 29.2 15.2 25.3  
Corynebacterium spp. 11.6 14.5 10.6 13.4  
C. tuberculostearicum 2.3 4.9 3.1 3.6  
C. aurimucosum/accolens 1.6 2.6 2.3 4.7  
C. afermentans 4.0 5.5 1.4 2.3  
C. mucifaciens 1.4 2.6 1.3 2.6  
Micrococcus luteus 0.8 1.5 8.4 12.2  
Actinomyces 1.9 2.6 0.08 0.1  
Microbacterium 0.01 0.3 1.3 2.2  
Kocuria 0.39 0.9 3.6 5.0  
K. palustris 0.2 0.7 2.9 5.2  
Firmicutes
Staphylococcus spp. 16.5 11.3 14.1 16.4  
S. capitis/S. caprae 9.9 6.1 11.4 17  
S. petrasii 5.4 7 1.7 2.5  
Streptococcus spp. 7.0 16.7 1.2 2.0  
S. mitis 5.7 13.6 0.3 4  
Nosocomiicoccus 1.3 246 0 0 
Finegoldia spp. 1.1 1.8 0.4 0.8  
F. magna 1.0 1.7 0.4 0.8  
Aerococcus urinaeequi/A. viridans 1.3 2.5 0.13 0.2  
Proteobacteria
Paracoccus spp. 0.15 0.3 17.8 20.6  
P. aminovorans 0.08 0.17 12.2 21.9  
P. versutus 0.06 0.2 4.1 7.1  
Haematobacter massiliensis 0.05 0.2 7.2 12.4  
Sphingomonas spp. 0.5 1.2 2.9 4.6  
S. hankookensis 0.3 1.0 2.8 4.8  
Mesorhizobium amorphae 1.0 2.8 0.5 1.7  
Bacteroidetes
Porphyromonas 1.7 5.2 0.18 0.4  
Chryseobacterium 0.2 0.5 1.5 2.7  
Prevotella 1.2 1.7 0.4 0.6  
Flavobacterium 0.8 0.8 0.2 0.4  
a R, resolvers; P, pustule formers.
b Each dot represents a volunteer in which the respective genus or species was detected.
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via the two models generally produced the same signature taxa.
We report the relative abundance of each signature phylum, ge-
nus, and species in Table 3. More detailed information regarding
signature taxa is compiled in Tables S2, S3, and S4 in the supple-
mental material.
At preinfection, the genus Propionibacterium was significantly
overrepresented in the resolvers; the major Propionibacterium
species, P. acnes, trended toward being significantly overrepre-
sented in resolvers (Table 3). Propionibacterium and P. acnes re-
mained associated with resolution on day 2 and at the endpoint.
Likewise, the phylum Actinobacteria was higher in resolvers on
day 2.
In contrast, the phylum Proteobacteria was significantly more
abundant in pustule formers at preinfection, days 1 and 2, and at
TOC. The genus Kocuria (family Micrococcacae) was also associ-
ated with pustule formation on day 1. The genus Micrococcus was
significantly overrepresented in pustule formers on days 1, 2, and
5, at the endpoint, and at TOC. Likewise, the dominant micrococ-
FIG 4 Nonmetric multidimensional scaling using Bray-Curtis dissimilarity of OTUs detected in preinfection samples from resolvers (R; n 10) and pustule
formers (P; n 10) (P 0.001, PERMANOVA). Samples that contained fewer than 450 sequence reads were excluded from the analysis. At preinfection, resolver
sites and sites within volunteers clustered.
FIG 5 Nonmetric multidimensional scaling using Bray-Curtis dissimilarity of OTUs detected in endpoint samples from resolved sites (R; n 11) and pustule
sites (P; n 9) (P 0.001, PERMANOVA). At the endpoint, pustule sites and sites within volunteers clustered.
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cal species, M. luteus, was associated with pustule formation on
day 1 and at the endpoint.
Other bacteria associated with pustule formers included the
phylum Bacteroidetes, which was significantly overrepresented on
day 2 and at TOC. Similarly, Flavobacterium was higher in pustule
formers on day 1, the endpoint, and TOC. The genus Corynebac-
terium and 2 dominant species, C. tuberculostearicum and C. au-
rimucosum/C. accolens, were associated with pustule formers on
day 5 and at the endpoint and TOC.
The abundance of the genus Haemophilus was significantly
higher in pustule formers at the endpoint. H. ducreyi was the only
Haemophilus species detected. Another member of the Proteobac-
teria, Paracoccus, trended toward being significantly associated
with pustule formation at the endpoint and was significantly dif-
ferent at TOC. The genus Staphylococcus was significantly over-
represented in pustule formers at the endpoint, and the OTU clas-
sified as S. capitis/S. caprae was higher at the endpoint and TOC.
Local and systemic treatments do not impact the micro-
biome. We wondered whether any changes in the microbiome
occurred due to systemic treatment with ciprofloxacin (resolved
sites) or treatment with ciprofloxacin along with punch biopsy,
suture, and topical bacitracin application (pustule sites). Because
the procedures differed between resolvers and pustule formers,
directly comparing the two groups was not appropriate. Rather,
we compared the Bray-Curtis dissimilarity values between the
endpoint and TOC samples to Bray-Curtis values between any
other 2 days within each group. The differences between the end-
point and TOC were not significantly different from the dissimi-
larities between any other day, for either resolvers or pustule
formers (data not shown). These results suggest that the treatment
at the endpoint did not significantly impact changes in the micro-
biome. At TOC the microbiome of the resolved sites in the pustule
formers, which were not biopsied, resembled their adjacent
pustule-forming sites, suggesting that the biopsy and topical bac-
itracin did not significantly alter the microbiome (Fig. 3).
DISCUSSION
In this study, we examined the bacterial communities on the up-
per arms of 8 volunteers before and after inoculation with H. du-
creyi. The microbiomes were similar to those of reported forearm
microbiomes (1, 2, 5). At preinfection, we found the skin of the
deltoid region to be largely dominated by Actinobacteria, Firmic-
utes, Proteobacteria, and Bacteroidetes. Similarly, a recent study on
two human volunteers who were asked not to bathe 3 days prior to
sampling identified these 4 phyla and Cyanobacteria on the upper
arm (38). In contrast, the same study found low levels of Propi-
onibacterium and Staphylococcus on the upper arm, whereas these
genera comprised a large proportion of our volunteers’ micro-
biomes. Both studies identified moderate levels of Corynebacte-
rium on the upper arm, and we found moderate levels of Strepto-
coccus, Paracoccus, and Micrococcus species. We did not ask our
participants to refrain from bathing prior to infection; perhaps
hygiene and person-to-person variations contributed to the dif-
ferences in the studies.
In our longitudinal study, we tracked changes in the micro-
biome over a 1- to 2-week period, compared the bacterial com-
munities in 3 adjacent sites on the upper deltoid region, and iden-
tified differences in the microbiome between resolvers and pustule
formers. Although the skin was cleansed with Betadine and etha-
nol prior to experimental infection, the microbiome was reestab-
lished within 24 h. In general, the bacterial community on each
volunteer’s arm changed over the course of the 6 samplings. Fur-
thermore, the changes were consistent across the 3 sites spaced
3 cm apart, suggesting that the intrinsic (temperature, pH, im-
TABLE 3 Relative abundance of signature taxa in resolvers and pustule formersa
Outcome and signature taxonomical group
Relative abundance (%) at:
Pre Day 1 Day 2 Day 5 End TOC
Organisms in resolvers
Propionibacterium spp. 39.99b 42.3 39.2b
P. acnes 38.97b* 42.02 38.3
Actinobacteria 58.3b
Organisms in pustule formers
Proteobacteria 37.4 14.4 18.2 16.4
Kocuria 1.9c
Micrococcus spp. 6.4b 2.1c 4.7 4.3c 7.4b
M. luteus 5.9 4.3
Flavobacterium 1.1c 0.5
Bacteroidetes 6.5 2.6
Corynebacterium spp. 17.6 12.7 11.2
C. tuberculostearicum 4.00 5.9c 4.95 5.9
C. aurimucosum/C. accolens 8.7 6.03 2.6
Haemophilus 10.2b
Paracoccus 3.3* 12.4
Staphylococcus spp. 41.4
S. capitis/S. caprae 30.8b 24.6
Firmicutes 46.0b 40.4b
Unclassified 1.0
a A taxonomical group was considered “signature” if it was detected in25% of sites, comprised1% (at the phylum or genus level) or 0.1% (at the OTU level) of the total
microbiome of resolvers or pustule formers, and its relative abundance was significantly different (P 0.05) between resolvers and pustule formers. Pre, preinfection; End,
endpoint. *, trended towards significance.
b The NB model fit the data better.
c The ZINB model fit the data better.
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mune response) and extrinsic (environment, hygiene, etc.) factors
influencing the microbiome were conserved across the deltoid
region of each volunteer.
To understand the interaction between the microbiome and
H. ducreyi infection, we compared the bacterial communities of
resolvers and pustule formers. Community ecological theory pre-
dicts that resistance to invading species correlates with high spe-
cies diversity (39). The effect of community diversity has also been
addressed in psoriasis; there is no consensus regarding whether
higher diversity (3) or lower diversity (40) is associated with pso-
riatic lesions compared to unaffected or healthy skin. We hypoth-
esized that a more diverse bacterial community present at both
preinfection and the endpoint would correlate with resolution of
H. ducreyi infection. However, alpha diversity measurements be-
tween resolvers and pustule formers were not significantly differ-
ent on any day. The data suggest that community diversity, rich-
ness, and evenness do not contribute to protection from or
susceptibility to H. ducreyi.
Although we did not find differences in diversity, community
composition differed between resolvers and pustule formers at
both preinfection and the endpoint. At preinfection, the micro-
biomes on the arms of resolvers were more similar to each other
and were significantly different than the microbiomes present in
the pustule formers. Host factors also influenced the microbiome,
as sites from the same volunteer tended to cluster together; this
effect was observed in samples analyzed at both preinfection and
the endpoint.
Infection outcome also played a role in community composi-
tion; the microbiomes differed between resolvers and pustule
formers at the endpoint. In contrast to what was found at prein-
fection, at the endpoint the microbiomes in pustule sites clustered
together. Furthermore, 10 signature bacteria were significantly
overrepresented in pustule-forming sites at the endpoint. These
data suggest that pustule formation, which coincides with an in-
effective hyperinflammatory immune response, is associated with
a shift toward a more similar community composition. Similarly,
Horton and colleagues found that in patients with abscesses
caused by S. aureus, the microbiomes of periabscess and contralat-
eral skin were more similar to each other than to the microbiomes
of control samples obtained from uninfected volunteers (41). Ad-
ditionally, natural and experimental infection with the fungal
pathogen Batrachochytrium dendrobatidis drives common
changes in the skin bacterial communities of frogs (42). We also
found that the resolved sites of pustule formers maintained bac-
terial communities similar to adjacent pustule sites, suggesting
that host factors have a strong influence on the microbiome. Con-
sistent with this host effect, the microbiome of the skin adjacent to
S. aureus abscesses resembles the microbiome of the uninfected
contralateral arm within the same person (41). Taken together,
these results suggest that the community structure of the skin
microbiome is associated with susceptibility to infection and that
the skin microbiomes of infected hosts converge toward a similar
composition, perhaps driven by the persistence of the host im-
mune response that failed to clear the pathogen. These observa-
tions may have important implications regarding the host-
microbiome interactions in our understanding the susceptibility
and treatment of skin infections.
Relative to preinfection, we anticipated that shifts in richness,
evenness, and community composition in pustule-forming sites
would coincide with the failure of the immune system (day 2 or
day 5, when pustules appear) and increased abundance of H. du-
creyi (endpoint). However, the relative changes in alpha or beta
diversity throughout the experimental infection did not differ sig-
nificantly between resolvers and pustule formers. The lack of sig-
nificant differences in temporal changes in alpha or beta diversity
was likely due to the small sample size and the high variance be-
tween the four volunteers, which could mask any temporal
changes. Perhaps sampling of larger cohorts would reveal day-to-
day shifts in alpha and beta diversity indices that would corre-
spond to the observed disease state.
H. ducreyi was detected in endpoint samples of pustule form-
ers. We hypothesized that an increased proportion of H. ducreyi
would drive down the diversity at the pustule sites; however, no
difference in Shannon or Simpson diversity indices between pus-
tule sites and resolved sites was observed at either the endpoint or
on each day of experimental infection relative to the endpoint.
Thus, although H. ducreyi can comprise a large proportion of the
microbiome (up to 30%), the alpha diversity measurements sug-
gest that H. ducreyi does not completely alter the microbiome.
This observation is in contrast to sites of atopic dermatitis flares,
where staphylococci dominate the microbiome and diversity con-
comitantly decreases (7).
Despite the high variance within the clinical groups, specific
taxa were associated with disease outcome. Proteobacteria, Bacte-
roidetes, Micrococcus, Corynebacterium, Paracoccus, and Staphylo-
coccus were significantly overrepresented in pustule-forming sites
on at least 1 day throughout the infection. Members of these phyla
and genera may present an advantage to H. ducreyi, represent a
disrupted infection-susceptible community, or thrive in the hu-
mid, inflamed pustular environments. On the other hand, Actino-
bacteria and Propionibacterium were significantly associated with
resolvers. These bacteria may protect against infection by outcom-
peting H. ducreyi, secreting factors that inhibit H. ducreyi growth
or by stimulating the immune system in a protective manner.
Alternatively, the presence of these taxa may reflect a bias of the
innate immunity of the infected host.
Our samples were obtained by swabbing the skin at the inocu-
lation sites. Grice and colleagues showed that skin samples ob-
tained by swab, scrape, or punch biopsy were highly similar and
sufficiently represented the bacterial community (43). Thus, our
sampling method likely captured an accurate representation of the
total microbiome, further supported by the detection ofH. ducreyi
in higher levels in the pustule sites than in resolved sites.
Changes in the microbiome during infection or a disease state
may be due to direct interactions between the invading pathogen
and the commensal bacteria, by the host immune response, or by
a combination of the two. One study showed that chemically or
genetically induced host-mediated inflammation perturbed the
composition of the mouse intestinal microbiome, whereas both
enteropathogenic infection and the host inflammatory response
were necessary to significantly reduce the number of intestinal
microbes (34). Grice and colleagues established a correlation be-
tween an increase in Staphylococcus spp. and a persistent inflam-
matory cutaneous immune response in chronic wounds of dia-
betic mice (44). Lastly, patients with primary immunodeficiencies
characterized by STAT1/STAT3 mutations and Th17 defects
showed increased levels of Gram-negative bacteria, such as Acin-
etobacter spp., and decreased levels of Corynebacterium spp. in the
skin microbiome (45). Those authors demonstrated that this shift
in the microbiota had the capacity to impair host defense re-
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sponses against staphylococci and Candida spp., which are com-
monly responsible for disease flares in these patients (45). These
studies supported the notion that the changes we observed in the
skin microbiome are likely due to the cutaneous immune response
mounted against H. ducreyi and that changes in the microbiota
can in turn affect the immune response.
Susceptibility to H. ducreyi infection is influenced by gender;
men are more likely than women to form pustules or ulcers in
both experimental and natural infections (16, 46, 47). Gender
influences on the skin microbiome (6) and differences in the skin
microbiomes between men and women may offer clues to the
gender disparity observed in H. ducreyi infection. Three of four
pairs of our volunteers were gender matched, but our study was
not designed to address gender effects on the skin microbiome or
how this factor relates to H. ducreyi susceptibility.
Except for participant 391A, all of the volunteers included in
this study had no previous exposure to H. ducreyi. In a previous
mutant-versus-parent trial (48) and in this study, all infected sites
in volunteer 391A resolved. This is consistent with the observation
that after a second challenge, resolvers tend to resolve infection
while pustule formers tend to form pustules (17, 28, 49). Thus,
there is evidence for differential host susceptibility to H. ducreyi
infection but no evidence for the development of protective im-
munity following challenge. All of the volunteers had not taken
antibiotics 1 month prior to infection; volunteer 391A was treated
with a single dose of ciprofloxacin 2 months prior to this chal-
lenge. We showed here that a single dose of ciprofloxacin has little
effect on the skin microbiome. Thus, it is unlikely that prior ex-
posure to the organism, protective immunity, or receipt of prior
antibiotics affected the study results for 391A or the other partic-
ipants.
In conclusion, we observed that the preinfection skin micro-
biome community structure is associated with susceptibility to
H. ducreyi infection and that the community structure appears to
change in response to pustule formation. Although H. ducreyi
comprises a large proportion of the bacterial community in pus-
tules, it does not cause total loss of community diversity. Host
effects and the cutaneous immune response appear to have strong
influences on microbiome composition, and several taxa were as-
sociated with pustule formation versus resolution. Further studies
analyzing the transcriptomes of signature taxa in pustule formers
and resolvers may shed light on functional differences between the
microbiomes of susceptible and resistant hosts and on how the
microbiome interacts with H. ducreyi. Additionally, analyzing the
microbiomes from persons with CU and GU naturally infected
with H. ducreyi may lend insight into the effect of H. ducreyi in-
fection on the microbiome.
MATERIALS AND METHODS
Human inoculation experiments. Fifteen consecutive healthy adult vol-
unteers who were infected in mutant-versus-parent challenge trials (ref-
erences 48 and 50 and unpublished data) and one volunteer (391A) who
was infected with the parent alone donated daily swabs for microbiome
analysis. The volunteers gave informed consent for participation and for
HIV serology in compliance with the human experimentation guidelines
of the U.S. Department of Health and Human Services and the Institu-
tional Review Board of Indiana University.
In the mutant-versus-parent trials, volunteers were inoculated over
the upper deltoid region on one arm at 3 sites with the parent strain,
35000HP, and at 3 sites on the other arm with an isogenic mutant derived
from 35000HP. The sites on each arm were vertically spaced 3 cm apart. A
resolver was defined as a participant who resolved at all 3 sites infected
with 35000HP. A pustule former was defined as a person who formed
pustules at 2 or 3 sites inoculated with 35000HP, regardless of the out-
come of the sites infected with the mutant strain. We included samples
from pairs of resolvers and pustule formers who were dose matched and
inoculated with at least 30 CFU of 35000HP. Of the 16 volunteers, 2 were
excluded because they were inoculated with doses of 30 CFU; 3 were
excluded because they formed only 1 pustule at parent-inoculated sites; 2
resolvers and 1 pustule former were excluded because they lacked a dose-
matched counterpart.
Samples from 4 pairs of dose-matched resolvers and pustule formers
were available for microbiome analysis (Table 1). The resolver group con-
sisted of two men and two women (mean age standard deviation [SD]
of 35.5 13.0 years), two of whom were African-American (AA) and two
of whom were European American (EA). The pustule-forming group
consisted of three men and one woman (mean age  SD, 38.5 
15.9 years), three of whom were EA and one of whom was AA.
Specimen collection and processing. On the day of H. ducreyi inocu-
lation, swabs were obtained from the 6 sites that were to be inoculated
with either the mutant or the parent prior to cleansing the skin with
Betadine and ethanol as required by the study protocol. The preinfection
swabs were processed and stored as described below except that they were
not cultured. Volunteers were examined daily on weekdays and followed
by phone on weekends for up to 14 days or until they achieved the clinical
endpoint, defined as resolution of a papule or development of a painful
pustule (16). At the endpoint, all volunteers were treated with a single
500-mg oral dose of ciprofloxacin. All of the pustule sites were biopsied
using a 6-mm punch biopsy forceps. Before biopsy, the skin was disin-
fected with ethanol; after biopsy, the skin was sutured and treated with
bacitracin. All volunteers returned 1 day after biopsy for a TOC visit.
For each visit, the volunteer was assigned a tube of sterile PBS. A sterile
Dacron swab was moistened in the PBS and rolled 10 times over one of the
six inoculation sites. The swab was then used to inoculate a chocolate agar
plate containing 3 g/ml vancomycin and was placed immediately in a
tube containing a DNA-stabilizing reagent (Gene Lock molecular speci-
men transport and preservation system; Sierra Molecular). This proce-
dure was repeated for each inoculated site; all six swabs were moistened in
the same tube of PBS. The tubes containing the Dacron swabs and the tube
containing the PBS were stored within 1 h at 20°C. After the code was
broken, swabs obtained from the parent-inoculated sites and the PBS
controls were processed for DNA isolation and microbiome analysis;
swabs from mutant-inoculated sites were not analyzed.
DNA isolation,multiplex 16S rRNAPCR, andpyrosequencing. Skin
and control swab samples were thawed, suspended in 1 ml PBS, and vor-
texed for 1 min. The resultant suspensions were pelleted by centrifugation
for 15 min at 4,000 g at 4°C. Genomic DNA (gDNA) was isolated using
a DNeasy blood and tissue extraction kit (Qiagen) according to the man-
ufacturer’s instructions, eluted in nuclease-free water, and stored at 4°C
until library construction. Reagent-only controls were processed in par-
allel to monitor for reagent contamination. The 16S rRNA gene V1-V3
region was amplified from 2l of gDNA using barcoded primers 27F and
534R as previously described (51). All 16S rRNA amplicons were quanti-
fied using the Quant-It high-sensitivity double-stranded DNA assay (Life
Technologies), pooled in equimolar concentrations, and sequenced on
the Roche/454 GS-FLX Titanium platform at the Indiana University Cen-
ter for Genomics and Bioinformatics, Bloomington, IN.
Sequence processing. The Mothur software (version 1.32.1) (52) was
used to process the 454 sequence reads as described previously (53).
Briefly, sequence reads were deconvoluted into individual samples based
on perfect matches to the barcode sequences. Primers and barcodes were
trimmed from each read, and trimmed sequences shorter than 200 bp
were discarded. Low-quality and chimeric sequences were removed with
default Mothur parameters. Using the built-in average-linkage clustering
algorithm of Mothur, the cleaned high-quality sequences were clustered
into species-level OTUs based on the commonly used 97% similarity cut-
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off. OTUs containing only one 16S rRNA sequence read were considered
a potential sequencing error; 1,387 singletons were omitted from the data
set. The OTU sequences were analyzed using BLAST (54) against the RDP
16S sequence database, release 11.1 (55), by first removing any RDP se-
quences derived from uncultured bacteria. Top BLAST hits were assigned
tentative species-level annotations if the BLAST alignment achieved
95% coverage and 97% sequence identity. Taxonomic classification
from phylum to genus levels of the sequence reads was performed by
using the RDP Classifier (version 2.5) (56) with a default 0.8 confi-
dence threshold.
To remove environmental contamination, we performed a data en-
richment step. For each OTU, the number of 16S sequence reads obtained
from the volunteers’ arm swabs were compared with the number of reads
from the PBS-only control swabs. The number of reads was normalized to
the number of samples obtained from each group (138 arm swabs, 46 PBS
control swabs). OTUs comprised of at least 2-fold-more normalized se-
quence reads from the arm swabs than those from the PBS control swabs
were retained; the rest were considered background and were omitted
from the data set. We chose the 2-fold cutoff to remove environmental
contaminants from the taxa list and to retain taxa that represent the skin
microbiota. The remaining OTUs were analyzed and compiled into their
respective genera and phyla for further analysis.
Sequence analysis and statistics. To minimize unequal sampling ef-
fects, 500 16S sequences were randomly subsampled without replacement
from each sample to achieve equal sequencing depth. The subsampling
was repeated 10 times, and the average taxa counts were used for the
subsequent data analysis. The data were then filtered to exclude samples
with fewer than 450 reads. The cutoff of 450 reads retained 93% of the
samples, allowing us to maximize power from our small cohort while
excluding samples that had inadequate sequence coverage. Nine samples
had fewer than 450 reads and were excluded from statistical analysis (see
Table S1 in the supplemental material). The R statistical package was used
for the statistical analyses. The R packages phyloseq (57) and vegan (58)
were used to determine Bray-Curtis dissimilarities, Shannon and Simp-
son diversity indices, Chao1 and ACE richness estimates, and Pielou even-
ness. NMDS analysis of microbial communities was performed using
Bray-Curtis dissimilarity values. The PERMANOVA was applied to test
whether within-group distances were significantly different from the
between-group distances. Weighted and unweighted Unifrac analyses
were done to confirm the results of the Bray-Curtis analyses (59, 60). The
negative binomial mixed model and zero-inflated negative binomial
mixed model (glmmADBM of the R package) were applied to analyze
whether any taxa were significantly different between pustule formers and
resolvers, as recommended by Fang and colleagues (37). We focused on
the phylum, genus, and OTU levels, based on precedents in the published
literature (2, 3, 61). Briefly, a taxa count was used as the response variable;
the predictor was the clinical outcome (i.e., a dichotomous categorical
variable for either pustule forming or resolved). The model also consid-
ered age, gender, and ethnic group as confounding factors. The repeated
measurements from the same subject were modeled as random effects.
Using the R package glmPQL, a generalized linear mixed model was em-
ployed to test whether any alpha diversity indices (response variable) were
different between pustule formers and resolvers (predictor) by also con-
sidering age, gender, and ethnic group as confounding factors. Multiple
test corrections were performed with the Benjamini and Hochberg pro-
cedure (62). Corrected P values of less than 0.05 were considered signifi-
cant.
Nucleotide sequence accession number. All of the sequences and as-
sociated metadata were deposited with the NCBI Sequence Read Archive
(63) under the accession number SRP056364.
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